AI Summary

Researchers at the American Association for Cancer Research (AACR) conference presented a novel application of CAR-T cell therapy in treating smoldering multiple myeloma. This approach involves using CAR-T cells to target cancer cells in a specific geographic area of the body, rather than relying on the cells to circulate throughout the entire body. The method was developed by Merck, a pharmaceutical company, in collaboration with researchers. The implications of this technique are unclear, but it could potentially offer a more targeted and effective treatment option for patients with smoldering multiple myeloma.

AI summaries can be wrong sometimes—always verify important details using the source article.